Fortrea Clinical Research Unit

Dallas, Texas 75247

4 studies enrolling now · 23 studies all time

What they study most

Healthy, Healthy Participants, Healthy Volunteers, Obese, Obesity, Overweight, Type 2 Diabetes

Studies at this site

• A Study of LY4515100 in Healthy Participants — Recruiting now
• A Study of LY4065967 in Healthy Participants — Recruiting now
• A Study of LY3867070 in Healthy Participants — Recruiting now
• A Study of Mirikizumab Solution (LY3074828) in Healthy Participants — Recruiting now
• A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight — Completed
• A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity — Running, not enrolling
• A Study of Eloralintide (LY3841136) in Healthy Participants — Starting soon
• A Study of LY4005130 in Healthy Participants — Completed
• A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes — Running, not enrolling
• A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity — Running, not enrolling
• A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity — Completed
• A Study of Remternetug (LY3372993) in Healthy Participants — Completed
• A Study of LY3537031 in Overweight, Obese, and Healthy Participants — Running, not enrolling
• A Study of LY3532226 in Participants With Obesity — Completed
• A Bioequivalence Study of Citrate Free Mirikizumab (LY3074828) in Healthy Participants — Completed
• A Study of LY3841136 in Overweight and Obese Participants — Completed
• A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants — Completed
• A Study of LY3866288 in Healthy Participants — Completed
• A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics and the Effect of Probenecid on Povorcitinib Pharmacokinetics When Administered Orally to Healthy Adult Participants — Completed
• A Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repaglinide, Digoxin, Rosuvastatin in Healthy Participants — Completed
• Bioequivalence of a Zanubrutinib Tablet Compared to Capsules in Healthy Adult Participants — Completed
• Relative Bioavailability of Zanubrutinib Tablets Compared to Capsules and Effects of Food on the Pharmacokinetics of the Tablet in Healthy Adults — Completed
• A Study of LY3841136 in Healthy and Overweight Participants — Completed